B-cell-T-cell activation and interaction in common variable immunodeficiency

Human Immunology

Volumn 71, Issue 4, 2010, Pages 355-362

  Rezaei, Nima ^a,b,c   Wing, James B ^a   Aghamohammadi, Asghar ^b,c   Carlring, Jennifer ^a   Lees, Andrew ^d   Asgarian Omran, Hossein ^e   Pourpak, Zahra ^f   Sarrafnejad, Abdolfattah ^e   Kardar, Gholam A ^f   Shahrestani, Tahereh ^e   Masoumi, Farimah ^e   Zare, Ahad ^f   Saghafi, Shiva ^f   Sarrafzadeh, Shokouh ^f   Foster, Rachel A ^a   Heath, Andrew W ^a   Read, Robert C ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d NONE   (United States)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Activation; B cell; Common variable immunodeficiency; Cytokine; Proliferation; T cell

Indexed keywords

ANTIBODY; CD19 ANTIGEN; CD28 ANTIBODY; CD3 ANTIBODY; CD86 ANTIGEN; IMMUNOGLOBULIN D ANTIBODY; IMMUNOGLOBULIN D ANTIBODY DEXTRAN CONJUGATE; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ARTICLE; B LYMPHOCYTE ACTIVATION; CD4+ CD25+ T LYMPHOCYTE; CELL INTERACTION; CELLULAR IMMUNITY; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HUMAN; HUMORAL IMMUNITY; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; B-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; COMMON VARIABLE IMMUNODEFICIENCY; DEXTRANS; FEMALE; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN D; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PARACRINE COMMUNICATION; T-LYMPHOCYTES;

EID: 77950539355     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.01.019     Document Type: Article

References (35)

1. Cunningham-Rundles C., Bodian C. Common variable immunodeficiency: Clinical and immunological features of 248 patients. Clin Immunol 1999, 92:34-48.
2. Hammarstrom L., Vorechovsky I., Webster D. Selective IgA deficiency (SIgAD) and Common Variable Immunodeficiency (CVID). Clin Exp Immunol 2000, 120:225-231.
3. Aghamohammadi A., Farhoudi A., Moin M., Rezaei N., Kouhi A., Pourpak Z., et al. Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency. Clin Diagn Lab Immunol 2005, 12:825-832.
4. Spickett G.P. Current perspectives on Common Variable Immunodeficiency (CVID). Clin Exp Allergy 2001, 31:536-542.
5. Webster A.D. Clinical and immunological spectrum of common variable immunodeficiency (CVID). Iran J Allergy Asthma Immunol 2004, 3:103-113.
6. Aghamohammadi A., Lougaris V., Plebani A., Miyawaki T., Durandy A., Hammarström L. Predominantly antibody deficiencies. Primary Immunodeficiency Diseases: Definition, Diagnosis and Management 2008, Vol 1:97-130. Springer-Verlag, Berlin, Heidelberg. N. Rezaei, A. Aghamohammadi, L.D. Notarangelo (Eds.).
7. Chapel H., Cunningham-Rundles C. Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol 2009, 145:709-727.
8. Aghamohammadi A., Parvaneh N., Rezaei N. Common variable immunodeficiency: A heterogeneous group needs further subclassification. Expert Rev Clin Immunol 2009, 5:629-631.
9. Bayry J., Hermine O., Webster D.A., Levy Y., Kaveri S.V. Common variable immunodeficiency: The immune system in chaos. Trends Mol Med 2005, 11:370-376.
10. Goldacker S., Warnatz K. Tackling the heterogeneity of CVID. Curr Opin Allergy Clin Immunol 2005, 5:504-509.
11. Zhang L., Radigan L., Salzer U., Behrens T.W., Grimbacher B., Diaz G., et al. Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: Clinical and immunologic outcomes in heterozygotes. J Allergy Clin Immunol 2007, 120:1178-1185.
12. Goldacker S., Draeger R., Warnatz K., Huzly D., Salzer U., Thiel J., et al. Active vaccination in patients with Common Variable Immunodeficiency (CVID). Clin Immunol 2007, 124:294-303.
13. Rezaei N., Aghamohammadi A., Siadat S.D., Moin M., Pourpak Z., Nejati M., et al. Serum bactericidal antibody responses to meningococcal polysaccharide vaccination as a basis for clinical classification of common variable immunodeficiency. Clin Vaccine Immunol 2008, 15:607-611.
14. Rezaei N., Aghamohammadi A., Siadat S.D., Nejati M., Ahmadi H., Moin M., et al. Serum bactericidal antibody response to serogroup C polysaccharide meningococcal vaccination in children with primary antibody deficiencies. Vaccine 2007, 25:5308-5314.
15. Boncristiano M., Majolini M.B., D'Elios M.M., Pacini S., Valensin S., Ulivieri C., et al. Defective recruitment and activation of ZAP-70 in common variable immunodeficiency patients with T cell defects. Eur J Immunol 2000, 30:2632-2638.
16. Stagg A.J., Funauchi M., Knight S.C., Webster A.D., Farrant J. Failure in antigen responses by T cells from patients with common variable immunodeficiency (CVID). Clin Exp Immunol 1994, 96:48-53.
17. Di Renzo M., Zhou Z., George I., Becker K., Cunningham-Rundles C. Enhanced apoptosis of T cells in common variable immunodeficiency (CVID): Role of defective CD28 co-stimulation. Clin Exp Immunol 2000, 120:503-511.
18. Isgrò A., Marziali M., Mezzaroma I., Luzi G., Mazzone A.M., Guazzi V., et al. Bone marrow clonogenic capability, cytokine production, and thymic output in patients with common variable immunodeficiency. J Immunol 2005, 174:5074-5081.
19. Pastorelli G., Roncarolo M.G., Touraine J.L., Peronne G., Tovo P.A., de Vries J.E. Peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) produce reduced levels of interleukin-4, interleukin-2 and interferon-gamma, but proliferate normally upon activation by mitogens. Clin Exp Immunol 1989, 78:334-340.
20. Rezaei N., Aghamohammadi A., Kardar G.A., Nourizadeh M., Pourpak Z. T-helper 1 and 2 cytokines assay in patients with common variable immunodeficiency. J Investig Allergol Clin Immunol 2008, 18:449-453.
21. Rezaei N., Haji-Molla-Hoseini M., Aghamohammadi A., Pourfathollah A.A., Moghtadaie M., Pourpak Z. Increased serum levels of soluble CD30 in patients with common variable immunodeficiency and its clinical implications. J Clin Immunol 2008, 28:78-84.
22. Rezaei N., Aghamohammadi A., Mahmoudi M., Shakiba Y., Kardar G.A., Mahmoudi M., et al. Association of IL-4 and IL-10 gene promoter polymorphisms with common variable immunodeficiency. Immunobiology 2010, 215:81-87.
23. Rezaei N., Aghamohammadi A., Shakiba Y., Mahmoudi M., Jalali A., Moradi B., et al. Cytokine gene polymorphisms in common variable immunodeficiency. Int Arch Allergy Immunol 2009, 150:1-7.
24. Rezaei N., Amirzargar A.A., Shakiba Y., Mahmoudi M., Moradi B., Aghamohammadi A. Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency. Clin Exp Immunol 2009, 155:21-27.
25. Foster R.A., Carlring J., McKendrick M.W., Lees A., Borrow R., Read R.C., et al. Evidence of a functional B cell immunodeficiency in adults who experience serogroup C meningococcal disease. Clin Vaccine Immunol 2009, 16:692-698.
26. Snapper C.M., McIntyre T.M., Mandler R., Pecanha L.M., Finkelman F.D., Lees A., et al. Induction of IgG3 secretion by interferon gamma: A model for T cell-independent class switching in response to T cell-independent type 2 antigens. J Exp Med 1992, 175:1367-1371.
27. Halista S.M., Johnson-Robbins L.A., El-Mohandes A.E., Lees A., Mond J.J., Katona I.M. Characterization of early activation events in cord blood B cells after stimulation with T cell-independent activators. Pediatr Res 1998, 43:496-503.
28. Pecanha L.M., Snapper C.M., Lees A., Yamaguchi H., Mond J.J. IL-10 inhibits T cell-independent but not T cell-dependent responses in vitro. J Immunol 1993, 150:3215-3223.
29. Lyons A.B., Parish C.R. Determination of lymphocyte division by flow cytometry. J Immunol Methods 1994, 171:131-137.
30. Pons J., Ferrer J.M., Martinez-Pomar N., Iglesias-Alzueta J., Matamoros N. Costimulatory molecules and cytokine production by T lymphocytes in common variable immunodeficiency disease. Scand J Immunol 2006, 63:383-389.
31. Fischer M.B., Wolf H.M., Eggenbauer H., Thon V., Vogel E., Lokaj J., et al. The costimulatory signal CD28 is fully functional but cannot correct the impaired antigen response in T cells of patients with common variable immunodeficiency. Clin Exp Immunol 1994, 95:209-214.
32. North M.E., Akbar A.N., Borthwick N., Sagawa K., Funauchi M., Webster A.D., et al. Co-stimulation with anti-CD28 (Kolt-2) enhances DNA synthesis by defective T cells in common variable immunodeficiency. Clin Exp Immunol 1994, 95:204-208.
33. Denz A., Eibel H., Illges H., Kienzle G., Schlesier M., Peter H.H. Impaired up-regulation of CD86 in B cells of "type A" common variable immunodeficiency patients. Eur J Immunol 2000, 30:1069-1077.
34. -) B cells from patients with common variable immunodeficiency (CVID). Clin Exp Immunol 2002, 129:133-139.
35. Bayry J., Lacroix-Desmazes S., Kazatchkine M.D., Galicier L., Lepelletier Y., Webster D., et al. Common variable immunodeficiency is associated with defective functions of dendritic cells. Blood 2004, 104:2441-2443.